Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Added Value of SPECT/CT in the Evaluation of Endocrine and Neuroendocrine Tumors

NCT00230139 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT00230139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00230139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Added Value of SPECT/CT in the Evaluation of Endocrine and Neuroendocrine Tumors
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2002
Completion date
January 31, 2006
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocrine and neuroendocrine tumors